Neil Kramer

1.2k total citations
35 papers, 655 citations indexed

About

Neil Kramer is a scholar working on Rheumatology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Neil Kramer has authored 35 papers receiving a total of 655 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Rheumatology, 6 papers in Pathology and Forensic Medicine and 6 papers in Immunology. Recurrent topics in Neil Kramer's work include Systemic Lupus Erythematosus Research (8 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Eosinophilic Disorders and Syndromes (4 papers). Neil Kramer is often cited by papers focused on Systemic Lupus Erythematosus Research (8 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Eosinophilic Disorders and Syndromes (4 papers). Neil Kramer collaborates with scholars based in United States. Neil Kramer's co-authors include Elliot D. Rosenstein, H. Daniel Perez, Mark Zucker, Bruce J. Diamond, Christopher Christodoulou, John DeLuca, Benjamin H. Natelson, Ira M. Goldstein, Robert R. Rickert and Lee D. Kaufman and has published in prestigious journals such as New England Journal of Medicine, Cancer and The American Journal of Medicine.

In The Last Decade

Neil Kramer

32 papers receiving 606 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Neil Kramer United States 14 183 124 80 79 75 35 655
Uma Kumar India 18 457 2.5× 78 0.6× 96 1.2× 97 1.2× 78 1.0× 95 1.1k
Emõke Endreffy Hungary 16 111 0.6× 45 0.4× 67 0.8× 25 0.3× 63 0.8× 38 693
S. M. Natu India 14 85 0.5× 42 0.3× 99 1.2× 88 1.1× 33 0.4× 35 627
S. Larsen Denmark 20 136 0.7× 157 1.3× 79 1.0× 53 0.7× 136 1.8× 66 1.1k
Erol Erduran Türkiye 16 66 0.4× 104 0.8× 56 0.7× 34 0.4× 97 1.3× 95 842
Joseph Zimmerman Israel 15 85 0.5× 184 1.5× 88 1.1× 66 0.8× 37 0.5× 35 1.6k
Finola M Delamere United Kingdom 15 77 0.4× 73 0.6× 153 1.9× 90 1.1× 17 0.2× 26 889
Fu‐Huang Lin Taiwan 15 55 0.3× 80 0.6× 115 1.4× 45 0.6× 38 0.5× 68 836
Şevket Arslan Türkiye 13 112 0.6× 68 0.5× 43 0.5× 17 0.2× 54 0.7× 66 541
Hüseyin Tan Türkiye 16 96 0.5× 59 0.5× 168 2.1× 179 2.3× 123 1.6× 55 821

Countries citing papers authored by Neil Kramer

Since Specialization
Citations

This map shows the geographic impact of Neil Kramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil Kramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil Kramer more than expected).

Fields of papers citing papers by Neil Kramer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil Kramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil Kramer. The network helps show where Neil Kramer may publish in the future.

Co-authorship network of co-authors of Neil Kramer

This figure shows the co-authorship network connecting the top 25 collaborators of Neil Kramer. A scholar is included among the top collaborators of Neil Kramer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neil Kramer. Neil Kramer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rosenstein, Elliot D., et al.. (2023). Nodular Sarcoid Myositis Treated With Hydroxychloroquine Monotherapy. Cureus. 15(6). e41000–e41000. 1 indexed citations
2.
Kramer, Neil, et al.. (2022). Rheumatologic associations of microscopic colitis: A narrative review. Modern Rheumatology. 33(3). 441–447. 1 indexed citations
3.
Harrold, Leslie R., Ying Shan, Sabrina Rebello, et al.. (2020). Disease activity and patient-reported outcomes in patients with rheumatoid arthritis and Sjögren’s syndrome enrolled in a large observational US registry. Rheumatology International. 40(8). 1239–1248. 6 indexed citations
4.
Rosenstein, Rachel K., Richard S. Panush, Neil Kramer, & Elliot D. Rosenstein. (2014). Hypereosinophilia and Seroconversion of Rheumatoid Arthritis. Clinical Rheumatology. 33(11). 1685–1688. 7 indexed citations
5.
Rosenstein, Elliot D., et al.. (2012). Etanercept Therapy for Psoriatic Arthritis in the Presence of Recurrent Non–Hodgkin Lymphoma. JCR Journal of Clinical Rheumatology. 18(6). 301–303. 1 indexed citations
6.
Berman, Howard, et al.. (2011). Spontaneous Resolution of Apparent Radiation Associated Retroperitoneal Fibrosis. JCR Journal of Clinical Rheumatology. 17(8). 436–438. 1 indexed citations
7.
Rosenstein, Elliot D., et al.. (2010). ANCA‐positive vasculitis associated with simvastatin/ezetimibe: expanding the spectrum of statin‐induced autoimmunity?. International Journal of Rheumatic Diseases. 13(3). e29–31. 15 indexed citations
8.
Patel, Sheetal, Neil Kramer, & Elliot D. Rosenstein. (2010). Evolving Connective Tissue Disease Influenced by Splenectomy. JCR Journal of Clinical Rheumatology. 16(6). 280–283. 9 indexed citations
9.
Kramer, Neil, et al.. (2009). Spondyloarthropathy After Ampullary Carcinoma Resection. JCR Journal of Clinical Rheumatology. 15(5). 241–243. 1 indexed citations
10.
DeLuca, John, Christopher Christodoulou, Bruce J. Diamond, et al.. (2004). Working memory deficits in chronic fatigue syndrome: Differentiating between speed and accuracy of information processing. Journal of the International Neuropsychological Society. 10(1). 101–109. 65 indexed citations
11.
Rosenstein, Elliot D., et al.. (2003). Pilot study of dietary fatty acid supplementation in the treatment of adult periodontitis. Prostaglandins Leukotrienes and Essential Fatty Acids. 68(3). 213–218. 73 indexed citations
12.
Kramer, Neil, et al.. (2002). Methotrexate pneumonitis after initiation of infliximab therapy for rheumatoid arthritis. Arthritis Care & Research. 47(6). 670–671. 42 indexed citations
13.
Rosenstein, Elliot D., et al.. (2001). The Prevalence of Insulin Receptor Antibodies in Patients with Systemic Lupus Erythematosus and Related Conditions. JCR Journal of Clinical Rheumatology. 7(6). 371–373. 13 indexed citations
14.
Rosenstein, Elliot D., et al.. (2001). Comparison of the effects of ketoprofen on platelet function in the presence and absence of aspirin. The American Journal of Medicine. 111(4). 285–289. 13 indexed citations
15.
Rosenstein, Elliot D., Mark Zucker, & Neil Kramer. (2000). Giant cell myocarditis: Most fatal of autoimmune diseases. Seminars in Arthritis and Rheumatism. 30(1). 1–16. 58 indexed citations
16.
Rosenstein, Elliot D., et al.. (1996). Exacerbation of rheumatoid arthritis after termination of chemotherapy for breast carcinoma.. PubMed. 23(11). 1988–90. 7 indexed citations
17.
Rosenstein, Elliot D., et al.. (1995). Case Report:Langerhans Cell Histiocytosis Associated With Elevation of Angiotensin-Converting Enzyme Levels. The American Journal of the Medical Sciences. 310(2). 65–67. 3 indexed citations
18.
Rosenstein, Elliot D. & Neil Kramer. (1994). Occult subacute thyroiditis mimicking classic giant cell arteritis. Arthritis & Rheumatism. 37(11). 1618–1620. 5 indexed citations
19.
Rosenstein, Elliot D. & Neil Kramer. (1991). Felty's and pseudo-Felty's syndromes. Seminars in Arthritis and Rheumatism. 21(3). 129–142. 46 indexed citations
20.
Rosenstein, Elliot D., et al.. (1988). Colonic involvement in angioimmunoblastic lymphadenopathy resembling inflammatory bowel disease. Cancer. 61(11). 2244–2250. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Uma Kumar Breakdown of academic impact, for papers by Emõke Endreffy Breakdown of academic impact, for papers by S. M. Natu Breakdown of academic impact, for papers by S. Larsen Breakdown of academic impact, for papers by Erol Erduran Breakdown of academic impact, for papers by Joseph Zimmerman Breakdown of academic impact, for papers by Finola M Delamere Breakdown of academic impact, for papers by Fu‐Huang Lin Breakdown of academic impact, for papers by Şevket Arslan Breakdown of academic impact, for papers by Hüseyin Tan
Rankless by CCL
2026